فهرست نشریات علمی دسترسی آزاد ایران

BACKGROUND: Cyanoacrylate (CA) has been used as an embolizing agent in the treatment ofgreater saphenous vein (GSV) insufficiency in recent years and the results regarding the use ofthis method have started to be published. To the best of our knowledge, the publications inliterature do not mention about a significant negative effect of endovenous CA (EVCA)embolization. We aimed to evaluate the effects and undesirable events of this relatively newtreatment method and compare them with literature, using the follow-up data of our patients.METHODS: Patients who had GSV insufficiency for at least 3 months and were treated withEVCA embolization because of this disease were included in the study. Patients were excluded ifthey had deep vein thrombosis (DVT), excessive tortuous GSV, and peripheral neuropathy.Hospital archive records were reviewed and undesirable events like DVT, thrombophlebitis, andpain related to this treatment procedure were recorded.RESULTS: EVCA embolization procedure was performed in a total of 54 patients with an averageage of 49.36 ± 13.06 years for the purpose of treating GSV insufficiency. One patient wasobserved to develop n-butyl CA (NBCA) extension of approximately 5 mm from saphenofemoraljunction (SFJ) to the main femoral vein and painful thrombophlebitic reaction was observed in6 extremities at the first control examination.CONCLUSION: In our opinion, while EVCA embolization is a treatment option with similarsuccess rates to endovenous thermal ablation (EVTA), it should be kept in mind that there maybe a possibility of developing thrombophlebitis and NBCA extension or thrombus extension tothe deep veins.